Epidermal growth factor upregulates motility of Mat-Lylu rat prostate cancer cells partially via voltage-gated Na+ channel activity

Journal of Cellular Physiology

Volumn 215, Issue 1, 2008, Pages 77-81

  Ding, Yanning ^a,b   Brackenbury, William J ^a   Onganer, Pinar U ^a,c   Montano, Ximena ^a   Porter, Louise M ^a,d   Bates, Lucy F ^a,e   Djamgoz, Mustafa B A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d Coombe Girls School ^*  (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TETRODOTOXIN; VOLTAGE GATED SODIUM CHANNEL; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; SODIUM CHANNEL; TYRPHOSTIN;

ARTICLE; CANCER CELL; CELL DENSITY; CELL MIGRATION; CELL MOTILITY; ELECTRIC CURRENT; HUMAN; HUMAN CELL; INCUBATION TIME; METASTASIS; PATCH CLAMP; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; UPREGULATION; ANIMAL; CELL MOTION; CHANNEL GATING; DRUG EFFECT; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; RAT;

RATTUS;

ANIMALS; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; ION CHANNEL GATING; MALE; PROSTATIC NEOPLASMS; RATS; SODIUM CHANNELS; TETRODOTOXIN; TYRPHOSTINS; UP-REGULATION;

EID: 39149115129     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21289     Document Type: Article

References (53)

1. Abdul M, Hoosein N. 2001. Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells. Anticancer Res 21:2045-2048.
2. Allen DH, Lepple-Wienhues A, Cahalan MD. 1997. Ion channel phenotype of melanoma cell lines. J Membr Biol 155:27-34.
3. Atalay G, Cardoso F, Awada A, Piccart MJ. 2003. Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Ann Oncol 14:1346-1363.
4. Bennett ES, Smith BA, Harper JM. 2004. Voltage-gated Na(+) channels confer invasive properties on human prostate cancer cells. Pflugers Arch 447:908-914.
5. Blandino JK, Viglione MP, Bradley WA, Oie HK, Kim YI. 1995. Voltage-dependent sodium channels in human small-cell lung cancer cells: Role in action potentials and inhibition by Lambert-Eaton syndrome IgG. J Membr Biol 143:153-163.
6. Blum R, Kafitz KW, Konnerth A. 2002. Neurotrophin-evoked depolarization requires the sodium channel Na(V) 1.9. Nature 419:687-693.
7. Brackenbury WJ, Djamgoz MB. 2006. Activity-dependent regulation of voltage-gated Na(+) channel expression in Mat-LyLu rat prostate cancer cell line. J Physiol 573:343-356.
8. Brackenbury WJ, Djamgoz MB. 2007. Nerve growth factor enhances voltage-gated Na(+) channel activity and transwell migration in Mat-LyLu rat prostate cancer cell line. J Cell Physiol 210:602-608.
9. Brackenbury WJ, Chioni AM, Diss JK, Djamgoz MB. 2007. The neonatal splice variant of Nav1.5 potentiates in vitro metastatic behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 101:149-160.
10. Citri A, Yarden Y. 2006. EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol 7:505-516.
11. Connolly JM, Rose DP. 1990. Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16:209-218.
12. Connolly JM, Rose DP. 1991. Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19:173-180.
13. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. 1994. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478.
14. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G, Klocker H. 1996. Regulation of prostatic growth and function by peptide growth factors. Prostate 28:392-105.
15. Diaz D, Delgadillo D, Hernandez-Gallegoz E, Ramirez-Dominguez M, Hinojosa L, Ortiz C, Berumen J, Camacho J, Gomora J. 2007. Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer. J Cell Physiol 210:469-478.
16. + current in the Mat-LyLu cell line of rat prostate cancer. Int J Biochem Cell Biol 36:1249-1260.
17. Diss JK, Archer SN, Hirano J, Fraser SP, Djamgoz MB. 2001. Expression profiles of voltage-gated Na(+) channel alpha-subunit genes in rat and human prostate cancer cell lines. Prostate 48:165-178.
18. Diss JK, Fraser SP, Djamgoz MB. 2004. Voltage-gated Na+ channels: Multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur Biophys J 33:180-193.
19. Diss JK, Stewart D, Pani F, Foster CS, Walker MM, Patel A, Djamgoz MB. 2005. A potential novel marker for human prostate cancer: Voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis 8:266-273.
20. + channel activity. J Cell Sci 114:2697-2705.
21. Fraser SP, Salvador V, Manning EA, Mizal J, Altun S, Raza M, Berridge RJ, Djamgoz MB. 2003. Contribution of functional voltage-gated Na(+) channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer. I. lateral motility. J Cell Physiol 195:479-187.
22. Fraser SP, Diss JK, Chioni AM, Mycielska M, Pan H, Yamaci RF, Pani F, Siwy Z, Krasowska M, Grzywna Z, Brackenbury WJ, Theodorou D, Koyuturk M, Kaya H, Battaloglu E, Tamburo De Bella M, Slade MJ, Tolhurst R, Palmieri C, Jiang J, Latchman DS, Coombes RC, Djamgoz MB. 2005. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 11:5381-5389.
23. Fulgenzi G, Graciotti L, Faronato M, Soldovieri MV, Miceli F, Amoroso S, Annunziato L, Procopio A, Taglialatela M. 2006. Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility. Int J Biochem Cell Biol 38:1146-1159.
24. Gann PH, Klein KG, Chatterton RT, Ellman AE, Grayhack JT, Nadler RB, Lee C. 1999. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates. Prostate 40:248-255.
25. Grimes JA, Djamgoz MB. 1998. Electrophysiological characterization of voltage-gated Na(+) current expressed in the highly metastatic Mat-LyLu cell line of rat prostate cancer. J Cell Physiol 175:50-58.
26. Grimes JA, Fraser SP, Stephens GJ, Downing JE, Laniado ME, Foster CS, Abel PD, Djamgoz MB. 1995. Differential expression of voltage-activated Na(+) currents in two prostatic tumour cell lines: Contribution to invasiveness in vitro. FEBS Lett 369:290-294.
27. Isaacs JT, Isaacs WB, Feitz WF, Scheres J. 1986. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9:261-281.
28. Kim HG, Kassis J, Souto JC, Turner T, Wells A. 1999. EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol Histopathol 14:1175-1182.
29. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F. 1995. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 14:1084-1090.
30. Krasowska M, Grzywna ZJ, Mycielska ME, Djamgoz MB. 2004. Patterning of endocytic vesicles and its control by voltage-gated Na(+) channel activity in rat prostate cancer cells: Fractal analyses. Eur Biophys J 33:535-542.
31. Kreis W. 1995. Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer. Cancer Invest 13:296-312.
32. Labrakakis C, Patt S, Weydt P, Cervos-Navarro J, Meyer R, Kettenmann H. 1997. Action potential-generating cells in human glioblastomas. J Neuropathol Exp Neurol 56:243-254.
33. Laniado ME, Lalani EN, Fraser SP, Grimes JA, Bhangal G, Djamgoz MB, Abel PD. 1997. Expression and functional analysis of voltage-activated Na(+) channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol 150:1213-1221.
34. Limonta P, Dondi D, Maretti MM, Moretti RM, Negri-Cesi P, Motta M. 1995. Growth of the: androgen-dependent tumor of the prostate: Role of androgens and of locally expressed growth modulatory factors. J Steroid Biochem Mol Biol 53:401-405.
35. Liu W, Akhand AA, Kato M, Yokoyama I, Miyata T, Kurokawa K, Uchida K, Nakashima I. 1999. 4-Hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J Cell Sci 112:2409-2417.
36. Liu H, Sun H-Y, Lau C-P, Li G-R. 2007. Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes. J Mol Cell Cardiol 42:760-768.
37. Lopez-Perez M, Salazar EP. 2006. A role for the cytoskeleton in STAT5 activation in MCF7 human breast cancer cells stimulated with EGF. Int J Biochem Cell Biol 38:1716-1728.
38. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. 2006. Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts. Matrix Biol 25:202-212.
39. Montano X, Djamgoz MB. 2004. Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. FEBS Lett 571:1-8.
40. Mycielska ME, Fraser SP, Szatkowski M, Djamgoz MB. 2003. Contribution of functional voltage-gated Na(+) channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer. II. Secretory membrane activity. J Cell Physiol 195:461-469.
41. Neumann-Giesen C, Fernow I, Amaddii M, Tikkanen R. 2007. Role of EGF-induced tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton. J Cell Sci 120:395-106.
42. Onganer PU, Djamgoz MB. 2005. Small-cell lung cancer (human): Potentiation of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro. J Membr Biol 204:67-75.
43. Onganer PU, Seckl MJ, Djamgoz MB. 2005. Neuronal characteristics of small-cell lung cancer. Br J Cancer 93:1197-1201.
44. Patt S, Labrakakis C, Bernstein M, Weydt P, Cervos-Navarro J, Nisch G, Kettenmann H. 1996. Neuron-like physiological properties of cells from human oligodendroglial tumors. Neuroscience 71:601-611.
45. Roger S, Besson P, Le Guennec JY. 2003. Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochim Biophys Acta 1616:107-111.
46. Russell PJ, Bennett S, Stricker P. 1998. Growth factor involvement in progression of prostate cancer. Clin Chem 44:705-723.
47. Schalkwijk CG, Spaargaren M, Defize LH, Verkleij AJ, van den Bosch H, Boonstra J. 1995. Epidermal growth factor (EGF) induces serine phosphorylation-dependent activation and calcium-dependent translocation of the cytosolic phospholipase A2. Eur J Biochem 231:593-601.
48. Sherwood ER, Lee C. 1995. Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J Urol 13:290-296.
49. Smith P, Rhodes NP, Shortland AP, Fraser SP, Djamgoz MB, Ke Y, Foster CS. 1998. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett 423:19-24.
50. Toledo-Aral JJ, Brehm P, Halegoua S, Mandel G. 1995. A single pulse of nerve growth factor triggers long-term neuronal excitability through sodium channel gene induction. Neuron 14:607-611.
51. Turner T, Chen P, Goodly LJ, Wells A. 1996. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis 14:409-418.
52. Zhao M, Dick A, Forrester JV, McCaig CD. 1999. Electric field-directed cell motility involves up-regulated expression and asymmetric redistribution of the epidermal growth factor receptors and is enhanced by fibronectin and laminin. Mol Biol Cell 10:1259-1276.
53. Zolfaghari A, Djakiew D. 1996. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function. Prostate 28:232-238.